What Happened?
Austin, TX-based Lumos Pharma Appointed Lori Lawley as Chief Financial Officer
About the Company
Lumos Pharma, based in Austin, Texas, is an early stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency. Lumos Pharma is the exclusive licensee of technology and discoveries made in laboratories at the University of Cincinnati and has partnered with Key Opinion Leaders in the field and the United States National Institutes of Health to ensure success in developing a treatment for Creatine Transporter Deficiency.
About the Person
Lori Lawley is Chief Financial Officer at Lumos Pharma. Previously, Lori held various senior HR leadership roles in the industry.
Info Source
News
Short Profile